CompletedNot applicableNCT01925742

Study of the Efficacy of New Non-invasive Prenatal Tests for Screening for Fetal Trisomies Using Maternal Blood

Studying Down syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
CHU de Quebec-Universite Laval
Principal Investigator
Francois Rousseau, MD MSc FRCPC
Universite Laval and CHU de Quebec
Intervention
Integrated prenatal screening for Down's syndrome(other)
Enrollment
3819 enrolled
Eligibility
19 years · FEMALE
Timeline
2013 – 2017

Study locations (5)

Collaborators

Laval University · Genome Canada · Genome Quebec · Genome British Columbia · Canadian Institutes of Health Research (CIHR)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01925742 on ClinicalTrials.gov

Other trials for Down syndrome

Additional recruiting or active studies for the same condition.

See all trials for Down syndrome →

← Back to all trials